{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:28:11Z","timestamp":1778693291843,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejphar.2024.177092","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:42:36Z","timestamp":1730853756000},"page":"177092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Potential mechanism of perillaldehyde in the treatment of nonalcoholic fatty liver disease based on network pharmacology and molecular docking"],"prefix":"10.1016","volume":"985","author":[{"given":"Qian-qian","family":"Niu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ting","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2030-1807","authenticated-orcid":false,"given":"Peng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-ling","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177092_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24010102","article-title":"Ethnomedicinal, phytochemical and pharmacological investigations of perilla frutescens (L.) britt","volume":"24","author":"Ahmed","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2024.177092_bib2","doi-asserted-by":"crossref","first-page":"19475","DOI":"10.1074\/jbc.RA119.009868","article-title":"Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1\u03b1-FGF21 axis in mice","volume":"294","author":"Aljohani","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2024.177092_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Ayd\u0131n","year":"2018","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2024.177092_bib4","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2024.177092_bib5","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2024.177092_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2024.177092_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2023.01.039","article-title":"Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease","volume":"355","author":"Chikamatsu","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2024.177092_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.ejphar.2024.177092_bib9","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jhep.2023.07.031","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD","volume":"80","author":"De","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2024.177092_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the inflammasome in liver disease","volume":"17","author":"de Carvalho Ribeiro","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ejphar.2024.177092_bib11","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1080\/10408398.2021.1900060","article-title":"Recent development in biological activities and safety concerns of perillaldehyde from perilla plants: a review","volume":"62","author":"Erhunmwunsee","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ejphar.2024.177092_bib12","doi-asserted-by":"crossref","first-page":"20105","DOI":"10.1021\/acs.jafc.3c06498","article-title":"Nobiletin ameliorates hepatic lipid deposition, oxidative stress, and inflammation by mechanisms that involve the Nrf2\/NF-\u03baB Axis in nonalcoholic fatty liver disease","volume":"71","author":"Fan","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2024.177092_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1167\/iovs.61.6.51","article-title":"Perillaldehyde ameliorates Aspergillus fumigatus keratitis by activating the Nrf2\/HO-1 signaling pathway and inhibiting dectin-1-mediated inflammation","volume":"61","author":"Fan","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2024.177092_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejphar.2024.177092_bib15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","article-title":"Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation","volume":"19","author":"Farzanegi","year":"2019","journal-title":"Eur. J. Sport Sci."},{"key":"10.1016\/j.ejphar.2024.177092_bib16","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4315\/0362-028X-65.10.1545","article-title":"Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica","volume":"65","author":"Friedman","year":"2002","journal-title":"J. Food Protect."},{"key":"10.1016\/j.ejphar.2024.177092_bib17","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.31843","article-title":"Saroglitazar, a PPAR-\u03b1\/\u03b3 agonist, for treatment of NAFLD: a randomized controlled double-blind phase 2 trial","volume":"74","author":"Gawrieh","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2024.177092_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910545","article-title":"The role of PPAR alpha in the modulation of innate immunity","volume":"22","author":"Grabacka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177092_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177092_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2217\/fca-2016-0059","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-\u03b1","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol."},{"key":"10.1016\/j.ejphar.2024.177092_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.ejphar.2024.177092_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6889533","article-title":"The role and mechanism of oxidative stress and nuclear receptors in the development of NAFLD","volume":"2021","author":"Hong","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2024.177092_bib23","article-title":"Gentiopicroside improves non-alcoholic steatohepatitis by activating PPAR\u03b1 and suppressing HIF1","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177092_bib24","article-title":"The role and mechanism of perilla frutescens in cancer treatment","volume":"28","author":"Huang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2024.177092_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2022.03.006","article-title":"Macrophage SCAP contributes to metaflammation and lean NAFLD by activating STING-NF-\u03bab signaling pathway","volume":"14","author":"Huang","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.ejphar.2024.177092_bib26","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejphar.2024.177092_bib27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","article-title":"Animal models of NAFLD from a hepatologist's point of view","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2024.177092_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jhep.2023.03.039","article-title":"A TNF\u03b1\/Miz1-positive feedback loop inhibits mitophagy in hepatocytes and propagates non-alcoholic steatohepatitis","volume":"79","author":"Jin","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2024.177092_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom13081264","article-title":"Current clinical trial status and future prospects of PPAR-targeted drugs for treating nonalcoholic fatty liver disease","volume":"13","author":"Kamata","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2024.177092_bib30","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.3748\/wjg.v24.i25.2661","article-title":"Apoptosis and non-alcoholic fatty liver diseases","volume":"24","author":"Kanda","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2024.177092_bib31","doi-asserted-by":"crossref","first-page":"11963","DOI":"10.3390\/ijms140611963","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)","volume":"14","author":"Kanuri","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2024.177092_bib32","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.arteri.2021.10.001","article-title":"Dietary patterns in non-alcoholic fatty liver disease (NAFLD): stay on the straight and narrow path","volume":"34","author":"Katsiki","year":"2022","journal-title":"Cl\u00edn. Invest. Arterioscler."},{"key":"10.1016\/j.ejphar.2024.177092_bib33","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2024.177092_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2024.177092_bib35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1517\/13543776.2012.699042","article-title":"Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008-present)","volume":"22","author":"Lamers","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2024.177092_bib36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2024.177092_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70472","article-title":"Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA","volume":"10","author":"Lee","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.ejphar.2024.177092_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jhep.2023.10.025","article-title":"CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis","volume":"80","author":"Lei","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2024.177092_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109623","article-title":"RNF31 mediated ubiquitination of A20 aggravates inflammation and hepatocyte apoptosis through the TLR4\/MyD88\/NF-\u03baB signaling pathway","volume":"348","author":"Li","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2024.177092_bib40","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jep.2007.05.008","article-title":"Growth inhibitory and apoptosis inducing effect of Perilla frutescens extract on human hepatoma HepG2 cells","volume":"112","author":"Lin","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2024.177092_bib41","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1080\/21655979.2021.2001237","article-title":"Perillaldehyde inhibits bone metastasis and receptor activator of nuclear factor-\u03baB ligand (RANKL) signaling-induced osteoclastogenesis in prostate cancer cell lines","volume":"13","author":"Lin","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.ejphar.2024.177092_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1620\/tjem.2023.J043","article-title":"LCZ696 ameliorates tachycardia-induced cardiac calcium dyshomeostasis in the serca2\u03b1-dependent pathway","volume":"260","author":"Liu","year":"2023","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1016\/j.ejphar.2024.177092_bib43","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/oby.22964","article-title":"A fad too far? Dietary strategies for the prevention and treatment of NAFLD","volume":"28","author":"Moore","year":"2020","journal-title":"Obesity"},{"key":"10.1016\/j.ejphar.2024.177092_bib44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12032-022-01918-2","article-title":"Dietary flavonoid carvacrol triggers the apoptosis of human breast cancer MCF-7 cells via the p53\/Bax\/Bcl-2 axis","volume":"40","author":"Moradipour","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejphar.2024.177092_bib45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jidsp.5640228","article-title":"Hair follicle apoptosis and Bcl-2","volume":"4","author":"M\u00fcller-R\u00f6ver","year":"1999","journal-title":"J. Invest. Dermatol. Symp. Proc."},{"key":"10.1016\/j.ejphar.2024.177092_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020818","article-title":"Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE((-\/-)) mice by activating autophagy and reducing ER stress and apoptosis","volume":"22","author":"Nasiri-Ansari","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177092_bib47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijpharm.2016.08.042","article-title":"Tissue distribution and enhanced in vivo anti-hyperlipidemic-antioxidant effects of perillaldehyde-loaded liposomal nanoformulation against Poloxamer 407-induced hyperlipidemia","volume":"513","author":"Omari-Siaw","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2024.177092_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejps.2016.02.003","article-title":"Hypolipidemic potential of perillaldehyde-loaded self-nanoemulsifying delivery system in high-fat diet induced hyperlipidemic mice: formulation, in vitro and in vivo evaluation","volume":"85","author":"Omari-Siaw","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejphar.2024.177092_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.metabol.2017.09.010","article-title":"Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease","volume":"81","author":"Qiao","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2024.177092_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/nu11030541","article-title":"Dietary polyphenols protect against oleic acid-induced steatosis in an in vitro model of NAFLD by modulating lipid metabolism and improving mitochondrial function","volume":"11","author":"Rafiei","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2024.177092_bib51","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1080\/10495398.2021.2025066","article-title":"Expression analysis of pro-apoptotic BAX and anti-apoptotic BCL-2 genes in relation to lactation performance in Deoni and Holstein Friesian crossbred cows","volume":"34","author":"Raj","year":"2023","journal-title":"Anim. Biotechnol."},{"key":"10.1016\/j.ejphar.2024.177092_bib52","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.ejphar.2024.177092_bib53","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2024.177092_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2008-1066544","article-title":"[Cor triatriatum in adulthood]","volume":"114","author":"Schymik","year":"1989","journal-title":"Dtsch. Med. Wochenschr."},{"key":"10.1016\/j.ejphar.2024.177092_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13578-019-0339-2","article-title":"BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling","volume":"9","author":"Sheng","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.ejphar.2024.177092_bib56","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/gutjnl-2020-323323","article-title":"Integrative study of diet-induced mouse models of NAFLD identifies PPAR\u03b1 as a sexually dimorphic drug target","volume":"71","author":"Smati","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2024.177092_bib57","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/hep.28820","article-title":"Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice","volume":"64","author":"Tanaka","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2024.177092_bib58","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejphar.2024.177092_bib59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2024.177092_bib60","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1039\/C7FO00090A","article-title":"Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-\u03b1 and Nrf2 activation, and NF-\u03baB down-regulation","volume":"8","author":"Valenzuela","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2024.177092_bib61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","volume":"34","author":"Wang","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejphar.2024.177092_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111641","article-title":"Perillaldehyde ameliorates lipopolysaccharide-induced acute lung injury via suppressing the cGAS\/STING signaling pathway","volume":"130","author":"Wei","year":"2024","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2024.177092_bib63","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.1998.533","article-title":"Bcl-2\/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance","volume":"78","author":"Williamson","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2024.177092_bib64","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/liv.15404","article-title":"Management of NAFLD in primary care settings","volume":"42","author":"Wong","year":"2022","journal-title":"Liver Int."},{"key":"10.1016\/j.ejphar.2024.177092_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1248376","article-title":"Programmed cell death and lipid metabolism of macrophages in NAFLD","volume":"14","author":"Xiao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2024.177092_bib66","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.3748\/wjg.v29.i31.4744","article-title":"Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1\/NF-\u03baB pathway","volume":"29","author":"Yan","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2024.177092_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175836","article-title":"Perillaldehyde improves diabetic cardiomyopathy by upregulating miR-133a-3p to regulate GSK-3\u03b2","volume":"953","author":"Yu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177092_bib68","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5304","article-title":"Role of transcription factor FOXM1 in diabetes and its complications","volume":"52","author":"Zhao","year":"2023","journal-title":"Int. J. Mol. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T01:28:54Z","timestamp":1733621334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":68,"alternative-id":["S0014299924007829"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177092","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential mechanism of perillaldehyde in the treatment of nonalcoholic fatty liver disease based on network pharmacology and molecular docking","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177092"}}